NYSE:KVUE 4 November 2025 - 18 January 2026

Kenvue shares closed at $17.20 Friday, down 0.35%, ahead of a Jan. 29 shareholder vote on its sale to Kimberly-Clark. Proxy adviser ISS recommended investors back the deal but cited ongoing legal and market risks. Kenvue updated merger disclosures after lawsuits challenged the process. The offer values Kenvue at about $18.03 per share, a 4.6% premium to Friday’s close.

Kenvue shares closed at $17.20 Friday after ISS recommended shareholders approve Kimberly-Clark’s $40 billion takeover bid. Kenvue filed updated merger disclosures following shareholder litigation. U.S. markets are closed Monday for Martin Luther King Jr. Day. Trading resumes Tuesday.

Kenvue shares rose 0.5% to $17.21 Thursday as Kimberly-Clark, its potential acquirer, gained 0.7% to $99.81, lifting the implied deal value to about $18.10 per Kenvue share. Investors focused on the spread ahead of Kenvue’s Jan. 29 shareholder meeting, with Tylenol litigation and regulatory approval risks in view.

Kenvue shares closed Friday down 1% at $16.83, nearly $1 below Kimberly-Clark’s implied takeover offer. Stockholders of both companies vote on the proposed merger Jan. 29, following Kimberly-Clark’s earnings release on Jan. 27. The deal values Kenvue at about $48.7 billion. The spread reflects ongoing deal risk and market uncertainty.

Kenvue shares fell 0.9% to $16.83 Friday, closing about 6% below the value implied by Kimberly-Clark’s takeover offer. The Options Clearing Corporation flagged a Jan. 29 shareholder vote and possible adjustments to Kenvue options tied to the deal. Kenvue updated filings, stating employees’ pay and benefits will remain steady if the merger closes in 2026.

The Options Clearing Corporation announced a planned adjustment for Kenvue options ahead of the Jan. 29 shareholder vote on its merger with Kimberly-Clark. Kenvue shares closed at $16.83, down about 1%. The new options deliverable will be 14 Kimberly-Clark shares plus $350 cash per 100-share contract if the deal closes. Kimberly-Clark reports earnings Jan. 27.

Kenvue shares rose 0.8% to $16.87 Thursday after law firm Kahn Swick & Foti said it is investigating the company’s pending sale to Kimberly-Clark. The offer values Kenvue at about $17.91 per share, a 6% premium to Thursday’s price. Shareholders are set to vote on the deal in late January. Kenvue also named Madhav Nayak as vice president and chief marketing officer for Asia-Pacific.

Kenvue shares traded near $17.33 midday Monday, about 7% below the implied $18.59 value of Kimberly-Clark’s pending cash-and-stock offer. The gap reflects market uncertainty as the $48.7 billion deal awaits regulatory and shareholder approval, with closing expected in the second half of 2026. Kimberly-Clark shares stood at $103.15. New legal filings and shareholder law firm activity surfaced Monday.